Risk Stratification of Myelodysplastic Syndromes
Hematologist-oncologists discuss the risk stratification of patients with myelodysplastic syndromes and how patient risk status determines prognosis.
Evolving Treatment Landscape Myelodysplastic Syndromes Mds Risk Stratification Prognostic Scoring Systems Evaluating Risk Ipss R
Source: onclive.com